Home
Search
Search Results
Previously Searched
3099 results found
Expand All
Apply All
3099 results found

Letter to the Honorable John Carey
Letters, Testimony & Comments  •  March 10, 2016
Letter to the Honorable John Carey, Chairman of the Senate Committee on Finance and Financial Institutions in Ohio from BIO, regarding House Bill 66.
Read More

Questions for the District of Columbia Board of Pharmacy for the drafting of SafeRx
Human Health  •  Letters, Testimony & Comments  •  March 10, 2016
Frequently Asked Questions Document
Read More

BIO Testimony regarding Oregan Senate Bill 570
Food & Farm Innovation  •  Letters, Testimony & Comments  •  March 10, 2016
Testimony to the Oregon Senate Environment & Land Use Committee regarding The Oregon Genetically Engineered Pharmaceutical and Industrial Crop Act.
Read More

Letter to Governor Deval Patrick
Letters, Testimony & Comments  •  March 10, 2016
BIO letter to Governor Deval Patrick of Massachusetts regarding concerns about Senate Bill 2863.
Read More

Clinical Trials: ICTRP guidelines
Letters, Testimony & Comments  •  March 10, 2016
BIO urges the ICTRP to focus on developing a procedure that would address the need to balance the incentive to innovate with the need to provide patients and health care providers with the information they need in order to assess the availability and suitability of a clinical trial.
Read More

Clinical Trials: Review of the Declaration of Helsinki
Letters, Testimony & Comments  •  March 10, 2016
BIO’s comments on the World Medical Association’s (WMA’s) Declaration of Helsinki.
Read More

2016 BIO International Convention Super Sessions Announced
Business Development, BIO One-on-One Partnering  •  Press Release  •  March 10, 2016
The Biotechnology Innovation Organization (BIO) announces the lineup for Super Sessions at the 2016 BIO International Convention, taking place in San Francisco’s Moscone Convention Center from June 6-9. Considered the global event for biotechnology, this year’s program is built around an “Imagine” theme.  Six Super Sessions will run during the course of the four day conference with topics on innovation and a look to the future.
Read More

BIO Applauds Advancement of Senate Biomedical Innovation Legislation
Press Release  •  March 9, 2016
BIO President and CEO Jim Greenwood released the following statement regarding today’s Senate HELP Committee mark-up of legislation as part of the Senate biomedical innovation initiative...
Read More

BIO Statement on Proposed Part B Drug Payment Model
Press Release  •  March 9, 2016
BIO Executive Vice President for Health Policy Dan Durham released the following statement regarding yesterday’s proposed Part B Drug Payment Model and ASPE Issue Briefs...
Read More

Dennis McGinn, Assistant Secretary of the Navy, to Deliver Remarks at the 2016 World Congress on Industrial Biotechnology
Press Release  •  March 6, 2016
The Biotechnology Innovation Organization (BIO) is pleased to announce that the Honorable Dennis McGinn, Assistant Secretary of the Navy, Energy, Installations & Environment, will address biofuel and biorefining technology developers. McGinn will provide remarks during the “Overcoming Challenges to Biorefinery Scale Up” plenary scheduled for 4:30pm on Monday, April 18th.
Read More